Mucosal vaccine-elicited IgA is protective against zoonotic Betacoronavirus challenge
This study demonstrates that an intranasal booster vaccine utilizing a synthetic consensus spike protein (SarbConS) delivered with ferritin nanoparticles and a specific adjuvant elicits durable, cross-protective mucosal IgA responses that are essential for defending against diverse zoonotic Betacoronaviruses, including SARS-CoV-2 and MERS-CoV.